A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma

Steven J. Cohen, Mark M. Zalupski, Paul Conkling, Francis Nugent, Wen Wee Ma, Manuel Modiano, Rolan Pascual, Fa Chyi Lee, Lucas Wong, Evan Hersh

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences